Please login to the form below

Not currently logged in

Boehringer and Lilly sway NICE with new Jardiance data


Diabetes drug now backed to help glycaemic control in adults

GSK set 'to cut 1,000 jobs' in China

GSK GlaxoSmithKline housePharma company's troubles in the country reportedly continue

Antibiotics among 7 new drugs backed by EMA

EU flagThe Medicines Company’s Orbactiv and Cubist’s Sivextro set for European approval

CHMP thumbs up for Novo's obesity drug Saxenda

Novo Nordisk headquartersDiabetes drug liraglutide on course for new indication in EU

FDA panel backs new antifungal Cresemba

FDA headquarters White OakBasilea/Astellas drug tipped to become a $500m product

NICE heart attack recommendation for Xarelto

Bayer Xarelto rivaroxaban 2.5Bayer drug on course for another blood clot indication in England and Wales

Havas Group acquires German comms agency Bird & Schulte

Freiburg-based firm will now operate as Havas Life Bird & Schulte

UCB submits brivaracetam for use in epilepsy

UCBFiles drug in both the US and EU

Genzyme's oral Gaucher drug cleared in Europe

genzyme officesCerdelga now available to adults with type 1 Gaucher disease

Sharing the 'chimp' and its effect on decision-marking

Pharma needs to learn how to dial up its emotional connectivity

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

How ethical is your brand plan? Introducing the hEQ.
Assess your brand plan’s Healthcare Ethics Quotient and see how these questions can give your brand plan a new perspective and engage your internal teams and external customers....
Why e-detailing must give options to healthcare professionals
We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible....
Is obesity really a problem in Brazil?
Obesity is on the rise in low- and middle-income countries, particularly in urban settings...